Postischemic myocardial stunning is superior to transient ischemic dilation for detecting multivessel coronary artery disease

Circulation Journal

Volumn 76, Issue 2, 2012, Pages 430-438

  Hida, Satoshi ^a   Chikamori, Taishiro ^a   Tanaka, Hirokazu ^a   Igarashi, Yuko ^a   Shiba, Chie ^a   Hatano, Tsuguhisa ^a   Usui, Yasuhiro ^a   Yamashina, Akira ^a  

^a TOKYO MEDICAL UNIVERSITY   (Japan)

Author keywords

Adenosine triphosphate; Coronary artery disease; Myocardial stunning; Quantitative gated singlephoton emission computed tomography; Transient ischemic dilation

Indexed keywords

ADENOSINE TRIPHOSPHATE; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; CORONARY ARTERY DISEASE; DIAGNOSTIC TEST ACCURACY STUDY; FEMALE; GATED SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY; HEART DILATATION; HEART EJECTION FRACTION; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HEART LEFT VENTRICLE ENDSYSTOLIC VOLUME; HEART LEFT VENTRICLE VOLUME; HEART MUSCLE ISCHEMIA; HEART STRESS; HUMAN; MAJOR CLINICAL STUDY; MALE; MYOCARDIAL PERFUSION IMAGING; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; STUNNED HEART MUSCLE; TRANSIENT ISCHEMIC DILATION;

ADENOSINE TRIPHOSPHATE; AGED; AGED, 80 AND OVER; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; CORONARY VESSELS; FEMALE; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; MYOCARDIAL ISCHEMIA; MYOCARDIAL PERFUSION IMAGING; MYOCARDIAL STUNNING; RADIOPHARMACEUTICALS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; TECHNETIUM TC 99M SESTAMIBI; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 84856302875     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.CJ-11-0946     Document Type: Article

References (30)

1. Johnson LL, Verdesca SA, Aude WY, Xavier RC, Nott LT, Campanella MW, et al. Post ischemic stunning can affect left ventricular ejection fraction and regional wall motion on post-stress gated sestamibi tomograms. J Am Coll Cardiol 1997; 30: 1641-1648.
2. Lima RS, Watson DD, Goode AR, Siadaty MS, Ragosta M, Beller GA, et al. Incremental value of combined perfusion and function over perfusion alone by gated SPECT myocardial perfusion imaging for detection of severe three-vessel coronary artery disease. J Am Coll Cardiol 2003; 42: 64-70.
3. Marcassa C, Galli M, Baroffio C, Campini R, Giannuzzi P. Transient left ventricular dilation at quantitative stress-rest sestamibi tomography: Clinical, electrocardiographic, and angiographic correlates. J Nucl Cardiol 1999; 6: 397-405.
4. Hida S, Chikamori T, Tanaka H, Usui Y, Igarashi Y, Nagao T, et al. Diagnostic value of left ventricular function after stress and at rest in the detection of multivessel coronary artery disease as assessed by electrocardiogram-gated SPECT. J Nucl Cardiol 2007; 14: 68-74.
5. Hida S, Chikamori T, Tanaka H, Igarashi Y, Hatano T, Usui Y, et al. Diagnostic value of left ventricular function after adenosine triphosphate loading and at rest in the detection of multi-vessel coronary artery disease using myocardial perfusion imaging. J Nucl Cardiol 2009; 16: 20-27.
6. Abidov A, Bax JJ, Hayes SW, Cohen I, Nishina H, Yoda S, et al. Integration of automatically measured transient ischemic dilation ratio into interpretation of adenosine stress myocardial perfusion SPECT for detection of severe and extensive CAD. J Nucl Med 2004; 45: 1999-2007.
7. Mazzanti M, Germano G, Kiat H, Kavanagh PB, Alexanderson E, Friedman JD, et al. Identification of severe and extensive coronary artery disease by automatic measurement of transient ischemic dilation of the left ventricle in dual-isotope myocardial perfusion SPECT. J Am Coll Cardiol 1996; 27: 1612-1620.
8. Abidov A, Bax JJ, Hayes SW, Hachamovitch R, Cohen I, Gerlach J, et al. Transient ischemic dilation ratio of the left ventricle is a significant predictor of future cardiac events in patients with otherwise normal myocardial perfusion SPECT. J Am Coll Cardiol 2003; 42: 1818-1825.
9. Igarashi Y, Chikamori T, Hida S, Tanaka H, Shiba C, Usui Y, et al. Importance of the ankle-brachial pressure index in the diagnosis of coronary artery disease in women with diabetes without anginal pain. Circ J 2011; 75: 2206-2212.
10. Yoshinaga K, Manabe O, Tamaki N. Physiological assessment of myocardial perfusion using nuclear cardiology would enhance coronary artery disease patient care: Which imaging modality is best for evaluation of myocardial ischemia? (SPECT-side) Circ J 2011; 75: 713-722.
11. Hachamovitch R, Berman DS, Kiat H, Cohen I, Cabico JA, Friedman J, et al. Exercise myocardial perfusion SPECT in patients without known coronary artery disease: Incremental prognostic value and use in risk stratification. Circulation 1996; 93: 905-914.
12. Germano G, Kiat H, Kavanagh PB, Moriel M, Mazzanti M, Su HT, et al. Automatic quantification of ejection fraction from gated myocardial perfusion SPECT. J Nucl Med 1995; 36: 2138-2147.
13. AHA committee report: A reporting system on patients evaluated for coronary artery disease. Circulation 1975; 51: 5-34.
14. Mock MB, Ringqvist I, Fisher LD, Davis KB, Chaitman BR, Kouchoukos NT, et al. Survival of medically treated patients in the coronary artery surgery study (CASS) registry. Circulation 1982; 66: 562-568.
15. Weiss AT, Berman DS, Lew AS, Nielsen J, Potkin B, Swan HJ, et al. Transient ischemic dilation of the left ventricle on stress thallium- 201 scintigraphy: A marker of severe and extensive coronary artery disease. J Am Coll Cardiol 1987; 9: 752-759.
16. Chouraqui P, Rodrigues EA, Berman DS, Maddahi J. Significance of dipyridamole-induced transient dilation of the left ventricle during thallium-201 scintigraphy in suspected coronary artery disease. Am J Cardiol 1990; 66: 689-694.
17. Lette J, Lapointe J, Waters D, Cerino M, Picard M, Gagnon A. Transient left ventricular cavitary dilation during dipyridamole-thallium imaging as an indicator of severe coronary artery disease. Am J Cardiol 1990; 66: 1163-1170.
18. McClellan JR, Travin MI, Herman SD, Baron JI, Golub RJ, Gallagher JJ, et al. Prognostic importance of scintigraphic left ventricular cavity dilation during intravenous dipyridamole technetium-99 m sestamibi myocardial tomographic imaging in predicting coronary events. Am J Cardiol 1997; 79: 600-605.
19. Einstein AJ, Weiner SD, Bernheim A, Kulon M, Bokhari S, Johnson LL, et al. Multiple testing, cumulative radiation dose, and clinical indications in patients undergoing myocardial perfusion imaging. JAMA 2010; 304: 2137-2144.
20. Fazel R, Krumholz HM, Wang Y, Ross JS, Chen J, Ting HH, et al. Exposure to low-dose ionizing radiation from medical imaging procedures. N Engl J Med 2009; 361: 849-857.
21. Berman DS, Kiat H, Friedman JD, Wang FP, van Train K, Matzer L, et al. Separate acquisition rest thallium-201/stress technetium-99 m sestamibi dual isotope myocardial perfusion SPECT: A clinical validation study. J Am Coll Cardiol 1993; 22: 1455-1464.
22. Chouraqui P, Rodrigues EA, Berman DS, Maddahi J. Significance of dipyridamole-induced transient dilation of the left ventricle during thallium-201 scintigraphy in suspected coronary artery disease. Am J Cardiol 1990; 66: 689-694.
23. Bateman TM, Maddahi J, Gray RJ, Murphy FL, Garcia EV, Conklin CM, et al. Diffuse slow washout of myocardial thallium-201: A new scintigraphic indicator of extensive coronary artery disease. J Am Coll Cardiol 1984; 4: 55-64.
24. Choy JB, Leslie WD. Clinical correlates of Tc-99 m sestamibi lung uptake. J Nucl Cardiol 2001; 8: 639-644.
25. Hansen CL, Sangrigoli R, Nkadi E, Kramer M. Comparison of pulmonary uptake with transient cavity dilation after exercise thallium- 201 perfusion imaging. J Am Coll Cardiol 1999; 33: 1323-1327.
26. Abidov A, Germano G, Berman DS. Transient ischemic dilation ratio: A universal high-risk diagnostic marker in myocardial perfusion imaging. J Nucl Cardiol 2007; 14: 497-500.
27. van der Veen BJ, Kuperij N, Stokkel MP. Transient ischemic dilatation ratio derived from myocardial perfusion scintigraphy: What are we looking at? J Nucl Cardio 2010; 7: 207-215.
28. Usui Y, Chikamori T, Nakajima K, Hida S, Yamashina A, Nishimura T, et al. Prognostic value of post-ischemic stunning as assessed by gated myocardial perfusion single-photon emission computed tomography: A subanalysis of the J-ACCESS study. Circ J 2010; 74: 1591-1599.
29. Nishimura T, Nakajima K, Kusuoka H, Yamashina A, Nishimura S. Prognostic study of risk stratification among Japanese patients with ischemic heart disease using gated myocardial perfusion SPECT: JACCESS study. Eur J Nucl Med Mol Imaging 2008; 35: 319-328.
30. Bonow RO, Maurer G, Lee KL, Holly TA, Binkley PF, Desvigne- Nickens P, et al. Myocardial viability and survival in ischemic left ventricular dysfunction. N Engl J Med 2011; 364: 1617-1625.